RAPT vs. SLGL

Last updated Jun 3, 2026

RAPT (RAPT Therapeutics, Inc.) and SLGL (Sol-Gel Technologies Ltd.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.12 correlation, their price movements are largely independent.

Performance

RAPT vs. SLGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RAPT Therapeutics, Inc. (RAPT) and Sol-Gel Technologies Ltd. (SLGL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

RAPT

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

SLGL

• 1D: 4.73%
• 1M: -2.49%
• YTD: 74.96%
• 6M: 90.39%
• 1Y: 918.37%
• 3Y*: 29.82%
• 5Y*: -6.19%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RAPT vs. SLGL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
RAPT RAPT Therapeutics, Inc.	71.30%	167.96%	-93.64%	25.51%	-46.09%	85.97%	-28.47%	112.38%
SLGL Sol-Gel Technologies Ltd.	74.96%	353.07%	-15.83%	-75.77%	-38.38%	-24.41%	-42.92%	114.38%

Correlation

The correlation between RAPT and SLGL is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.07
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (All Time) Calculated using the full available price history since Nov 1, 2019	0.12

Fundamentals

Market Cap RAPT : $1.56B SLGL : $209.17M
EPS RAPT : -$3.92 SLGL : -$0.37
PB Ratio RAPT : 10.29 SLGL : 4.07
Total Revenue (TTM) RAPT : $0.00 SLGL : $18.47M
Gross Profit (TTM) RAPT : -$200.00K SLGL : $18.47M
EBITDA (TTM) RAPT : -$108.01M SLGL : -$2.03M

Return for Risk

RAPT vs. SLGL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SLGL

SLGL Risk / Return Rank: 99
SLGL Sharpe Ratio Rank: 100
SLGL Sortino Ratio Rank: 98
SLGL Omega Ratio Rank: 97
SLGL Calmar Ratio Rank: 100
SLGL Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RAPT vs. SLGL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RAPT Therapeutics, Inc. (RAPT) and Sol-Gel Technologies Ltd. (SLGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RAPT	SLGL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	9.23	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.04	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.05	—

Drawdowns

Drawdown Indicators

	RAPT	SLGL	Difference
Max Drawdown Largest peak-to-trough decline	—	-97.87%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-35.38%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-90.71%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-97.24%	—
Current Drawdown Current decline from peak	—	-57.01%	—
Average Drawdown Average peak-to-trough decline	—	-62.78%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	14.28%	—

Volatility

Volatility by Period

	RAPT	SLGL	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	23.74%	—
Volatility (6M) Calculated over the trailing 6-month period	—	67.56%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	100.52%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	160.42%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	132.70%	—

Dividends

RAPT vs. SLGL - Dividend Comparison

Neither RAPT nor SLGL has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both RAPT and SLGL in my portfolio?

RAPT and SLGL have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.